These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27178513)

  • 1. Treatment of Meniere's disease with intratympanic dexamethazone plus high dosage of betahistine.
    Albu S; Nagy A; Doros C; Marceanu L; Cozma S; Musat G; Trabalzini F
    Am J Otolaryngol; 2016; 37(3):225-30. PubMed ID: 27178513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease.
    Albu S; Chirtes F; Trombitas V; Nagy A; Marceanu L; Babighian G; Trabalzini F
    Am J Otolaryngol; 2015; 36(2):205-9. PubMed ID: 25510210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease.
    Leng Y; Liu B; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
    Acta Otolaryngol; 2017 Feb; 137(2):154-160. PubMed ID: 27650470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
    Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
    [No Abstract]   [Full Text] [Related]  

  • 5. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière's disease compared with betahistine pharmacotherapy.
    Molnár A; Maihoub S; Tamás L; Szirmai Á
    J Int Med Res; 2021 Apr; 49(4):300060520985647. PubMed ID: 33845616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial.
    Casani AP; Piaggi P; Cerchiai N; Seccia V; Franceschini SS; Dallan I
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):430-7. PubMed ID: 22101095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
    Beyea JA; Instrum RS; Agrawal SK; Parnes LS
    Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
    Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
    PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
    Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
    J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
    Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
    Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.
    Scarpa A; Ralli M; Cassandro C; Gioacchini FM; Alicandri-Ciufelli M; Viola P; Chiarella G; de Vincentiis M; Cassandro E
    Am J Otolaryngol; 2019; 40(6):102289. PubMed ID: 31537428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
    Lambert PR; Carey J; Mikulec AA; LeBel C;
    Otol Neurotol; 2016 Dec; 37(10):1669-1676. PubMed ID: 27749754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing function after betahistine therapy in patients with Ménière's disease.
    Seyed Tootoonchi SJ; Ghiasi S; Shadara P; Samani SM; Fouladi DF
    Braz J Otorhinolaryngol; 2016; 82(5):500-6. PubMed ID: 26810620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.